Natriumhydrogencarbonat B. Braun (Sodium Hydrogen Carbonate)

Sodium hydrogen carbonate, the active ingredient in Natriumhydrogencarbonat B. Braun, is an alkali (buffer) presented as a sterile solution for injection for intravenous use. It treats metabolic acidosis and assists in correcting acid‑base disturbances in hospitalized patients.

GNH USA supplies Natriumhydrogencarbonat B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑compliant documentation for each batch, facilitating import and distribution across multiple regions. GNH USA also offers technical support and after‑sales service to ensure safe handling.

Natriumhydrogencarbonat B. Braun is used to correct acid‑base imbalances, primarily metabolic acidosis, by supplying bicarbonate ions. - Metabolic acidosis: restores systemic pH by providing bicarbonate ions, helping to normalize blood acidity. - Acid‑base disturbances: corrects systemic acidemia in various clinical settings, such as renal failure or severe diarrhea. - Urine alkalinization: raises urinary pH to facilitate excretion of certain toxins or improve solubility of drugs. - Adjunct in drug administration: used to prevent precipitation of acidic drugs or to enhance the efficacy of specific antimicrobial therapies.

Intravenous administration of sodium hydrogen carbonate may be associated with several adverse reactions, ranging from mild to severe.

Common Side Effects: - Hypernatremia: elevated serum sodium levels due to sodium load. - Metabolic alkalosis: excessive rise in blood pH if over‑corrected. - Fluid overload: increased intravascular volume leading to edema. - Local irritation: pain or phlebitis at the infusion site. - Transient CO₂ increase: temporary rise in arterial CO₂ during metabolism.

Serious or Rare Side Effects: - Severe metabolic alkalosis: can cause respiratory depression and neuromuscular irritability. - Pulmonary edema: fluid accumulation in lungs from rapid volume expansion. - Cardiac arrhythmias: electrolyte shifts may precipitate abnormal heart rhythms. - Anaphylactic reaction: rare hypersensitivity with hypotension and bronchospasm.

Before using Natriumhydrogencarbonat B. Braun, clinicians should consider several safety precautions to minimize risks. - Renal impairment: monitor serum electrolytes and acid‑base status closely. - Cardiac disease: watch for fluid overload and electrolyte‑induced arrhythmias. - Pregnancy: use only when potential benefit justifies potential risk to the fetus. - Concomitant alkalizing agents: avoid additive alkalosis by adjusting doses. - Administration technique: ensure correct dilution and controlled infusion rate to prevent rapid pH shifts. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Sodium hydrogen carbonate can interact with other medicines, affecting their absorption, distribution, or pharmacodynamic effects.

Major Interactions (Avoid): - Other alkalinizing agents (e.g., oral bicarbonate, citrate): risk of severe metabolic alkalosis. - Calcium channel blockers: may enhance hypotensive effect due to increased extracellular calcium. - Potassium‑wasting diuretics: can exacerbate hypokalemia when combined with bicarbonate therapy.

Moderate Interactions (Monitor Closely): - Certain antibiotics (e.g., tetracyclines, fluoroquinolones): bicarbonate may reduce their absorption. - Aspirin and other weak acids: increased ionization may diminish analgesic effect. - Anticonvulsants (e.g., phenobarbital): altered protein binding may modify drug levels.